Annual Current Liabilities
$184.00 M
-$9.00 M-4.66%
31 December 2023
Summary:
Arcus Biosciences annual total current liabilities is currently $184.00 million, with the most recent change of -$9.00 million (-4.66%) on 31 December 2023. During the last 3 years, it has risen by +$18.00 million (+10.84%). RCUS annual current liabilities is now -4.66% below its all-time high of $193.00 million, reached on 31 December 2022.RCUS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$215.00 M
+$16.00 M+8.04%
30 September 2024
Summary:
Arcus Biosciences quarterly total current liabilities is currently $215.00 million, with the most recent change of +$16.00 million (+8.04%) on 30 September 2024. Over the past year, it has increased by +$31.00 million (+16.85%). RCUS quarterly current liabilities is now at all-time high.RCUS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +16.9% |
| 3 y3 years | +10.8% | +29.5% |
| 5 y5 years | +710.4% | +846.9% |
RCUS Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4.7% | +10.8% | at high | +33.3% |
| 5 y | 5 years | -4.7% | +710.4% | at high | +923.6% |
| alltime | all time | -4.7% | +3217.7% | at high | +1589.5% |
Arcus Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $215.00 M(+8.0%) |
| June 2024 | - | $199.00 M(-2.5%) |
| Mar 2024 | - | $204.00 M(+10.9%) |
| Dec 2023 | $184.00 M(-4.7%) | $184.00 M(-8.0%) |
| Sept 2023 | - | $200.00 M(+11.1%) |
| June 2023 | - | $180.00 M(+0.6%) |
| Mar 2023 | - | $179.00 M(-7.3%) |
| Dec 2022 | $193.00 M(+16.3%) | $193.00 M(+8.9%) |
| Sept 2022 | - | $177.18 M(+8.0%) |
| June 2022 | - | $164.02 M(+1.7%) |
| Mar 2022 | - | $161.25 M(-2.9%) |
| Dec 2021 | $166.00 M | $166.00 M(+16.2%) |
| Sept 2021 | - | $142.87 M(+9.6%) |
| June 2021 | - | $130.37 M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $132.06 M(+8.5%) |
| Dec 2020 | $121.67 M(+435.8%) | $121.67 M(-25.3%) |
| Sept 2020 | - | $162.87 M(+306.9%) |
| June 2020 | - | $40.02 M(+90.6%) |
| Mar 2020 | - | $21.00 M(-7.5%) |
| Dec 2019 | $22.71 M(+34.1%) | $22.71 M(+7.8%) |
| Sept 2019 | - | $21.06 M(-20.6%) |
| June 2019 | - | $26.51 M(+39.5%) |
| Mar 2019 | - | $19.00 M(+12.2%) |
| Dec 2018 | $16.93 M(+33.1%) | $16.93 M(+2.0%) |
| Sept 2018 | - | $16.61 M(+1.4%) |
| June 2018 | - | $16.38 M(+14.9%) |
| Mar 2018 | - | $14.26 M(+12.1%) |
| Dec 2017 | $12.73 M(+129.5%) | $12.73 M |
| Dec 2016 | $5.55 M | - |
FAQ
- What is Arcus Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Arcus Biosciences?
- What is Arcus Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Arcus Biosciences?
- What is Arcus Biosciences quarterly current liabilities year-on-year change?
What is Arcus Biosciences annual total current liabilities?
The current annual current liabilities of RCUS is $184.00 M
What is the all time high annual current liabilities for Arcus Biosciences?
Arcus Biosciences all-time high annual total current liabilities is $193.00 M
What is Arcus Biosciences quarterly total current liabilities?
The current quarterly current liabilities of RCUS is $215.00 M
What is the all time high quarterly current liabilities for Arcus Biosciences?
Arcus Biosciences all-time high quarterly total current liabilities is $215.00 M
What is Arcus Biosciences quarterly current liabilities year-on-year change?
Over the past year, RCUS quarterly total current liabilities has changed by +$31.00 M (+16.85%)